Miralles Gines Diego has filed 5 insider transactions across 2 companies since March 2025.
Most recent transaction: a grant/award of 77500 shares of Artiva Biotherapeutics, Inc. ($ARTV) on May 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Miralles Gines Diego | President & Head of R&D | A | Common Stock | 77500 | $0.00 | 77,500.0000 | 24,544,904 | 9999.99% | 0.32% |
| May 18, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Miralles Gines Diego | President & Head of R&D | A | Employee Stock Option (Right to Buy) | 232500 | $0.00 | 232,500.0000 | 24,544,904 | 9999.99% | 0.95% |
| June 26, 2025 | Contineum Therapeutics, Inc. | $CTNM | Miralles Gines Diego | Director | A | Stock Option (right to buy) | 14750 | $0.00 | 14,750.0000 | 19,352,859 | 9999.99% | 0.08% |
| June 24, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Miralles Gines Diego | Not found | A | Director Stock Option (Right to Buy) | 13750 | $0.00 | 13,750.0000 | 24,363,119 | 9999.99% | 0.06% |
| March 14, 2025 | Contineum Therapeutics, Inc. | $CTNM | Miralles Gines Diego | Director | A | Stock Option (right to buy) | 29500 | $0.00 | 29,500.0000 | 19,352,859 | 9999.99% | 0.15% |